IntraMed - Artículos - Prevención secundaria de la preeclampsia
Medicina Preventiva | 26 FEB 03
Prevención secundaria de la preeclampsia
El conocimiento de la fisiopatología; los métodos de detección precóz y los medios para intervenir y corregir los cambios fisiopatológicos son la base de la prevención secundaria.
Autor: Dres. Dekker G, Sibai B Fuente: University of Adelaide, Lyell McEwin Hospital, North Western Adelaide Health Service, SA, Australia Lancet 2001 Jan 20;357(9251):209-15
Bibliografía


· Villar MA, Sibai BM. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during the third trimester. Am J Obstet Gynecol 1989; 160: 419-23.
· Conde-Agudelo A, Belizan JM, Lede R, Bergel EF. What does an elevated mean arterial pressure in the second half of pregnancy predict: gestatonal hypertension or preeclampsia? Am J Obstet Gynecol 1993; 169: 509-14.
· Dekker GA, Sibai BM. Early detection of preeclampsia. Am J Obstet Gynecol 1991; 165: 160-72.
· Masse J, Forest J-C, Moutquin J-M, Marcoux S, Brideau N-A, Belanger M. A prospective study of several potential biologic markers for early prediction of preeclampsia. Am J Obstet Gynecol 1993; 169: 501-08.
· Dawes MG, Grudzinskas JG. Repeated measurement of maternal weight during pregnancy: is this a useful practice? Br J Obstet Gynaecol 1991; 98: 189-94.
· Van Rijn M, van der Schouw YT, Hagenaars AM, Visser GHA, Christiaens GC. Adverse obstetric outcome in low-and high risk pregnancies: predictive value of maternal serum screening. Obstet Gynecol 1999; 94: 929-34.
· Walton DL, Norem CT, Schoen EJ, Ray T, Colby CJ. Second-trimester serum chorionic gonadotrophin concentrations and complications and outcome of pregnancy. N Engl J Med 1999; 341: 2033-38.
· Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variales in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994; 101: 488-92.
· Murphy JF, Newcombe RG, O'Riordan JO, et al. Relation of haemoglobin levels in first and second trimesters to outcome. Lancet 1986; 1: 992-94.
· Chappel L, Bewley S. Pre-eclamptic toxaemia: the role of uterine artery Doppler. Br J Obstet Gynaecol 1998; 105: 379-82.
· Chien PF, Arnott N, Gordon A, Owen P, Khan KS. How useful is uterine artery doppler flow velocimetry in the prediction of pre-eclampsia, intra-uterine growth retardation and perinatal death? An overview. Br J Obstet Gynaecol 2000; 107: 196-208.
· Marcoux S, Brisson J, Fabia J. Calcium intake from dairy products and supplements and the risks of preeclampsia and gestational hypertension. Am J Epidemiol 1991; 133: 1266-72.
· Atallah AN, Hofmeyr GJ, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Cochrane Review). In: The Cochrane Library Issue 1. Oxford: Update Software, 2000.
· DerSimonian R, Levine RJ. Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. JAMA 1999; 282: 664-70.
· Crowther CA, Hiller JE, Pridmore B, et al. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: an Australian randomized trial--FRACOG and the ACT Study Group. Aust NZ J Obstet Gynaecol 1999; 39: 12-18.
· Levine RJ and others. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337: 69-76.
· CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619-29.
· Dekker GA, Sibai BM. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. Am J Obstet Gynecol 1993; 168: 214-27.
· Knight M, Duley L, Henderson-Smart DJ, King JF. Antiplatelet agents and pre-eclampsia (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford, Uptade Software, 2000.
· Paarlberg KM, Jong de CLD, van Geijn HP, van Kamp GJ, Heinen AGLL, Dekker GA. Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study. Am J Obstet Gynecol 1998; 179: 1599-64.
· Goldenberg RL, Hauth JC, DuBard MB, Copper RL, Cutter GR. Fetal growth in women using low-dose aspirin for the prevention of preeclampsia--effect of maternal size. J Maternal Fetal Med 1995; 4: 218-24.
· Dumont A, Flahault A, Beaufils M, Verdy E, Uzan S. Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol 1999; 180: 135-40.
· Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. A meta-analysis of low-dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997; 104: 450-59.
· Emeagi J, Patni S, Tikum HM, Mander AM. Low dose aspirin for preventing and treating pre-eclampsia. BMJ 1999; 319: 316.
· Steyn DW, Odendaal HJ. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet 1997; 350: 1267-71.
· Leaf A, PC Weber. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 318: 549-57.
· Olsen S, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Br J Obstet Gynaecol 2000; 107: 382-95.
· Leeda M, Riazi N, de Vries JIP, Jakobs C, van Geijn HP, Dekker GA. Effects of folic acid and vitamin B6 on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998; 179: 135-39.
· Chappell LC, Seed PT, Briley AL, et al. Effects of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial.

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014